Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 11, 2020PLoS ONEOpen Access

A novel drug repurposing approach for non-small cell lung cancer using deep learning

View Full Paper
Ask AI
Bookmark
Share

Authors

BLBingrui LiCDChan DaiLWLijun Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2020) studied this question.

synapsesocial.com/papers/6a1097e34fb650da4fffb35dhttps://doi.org/10.1371/journal.pone.0233112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1COXPRESdb v7: a gene coexpression database for 11 animal species supported by 23 coexpression platforms for technical evaluation and evolutionary inference2018 · 168 citations
  2. 2In Vitro Optimization of Non-Small Cell Lung Cancer Activity with Troxacitabine, l -1,3-Dioxolane-cytidine, Prodrugs2007 · 16 citations
  3. 3Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines1990 · 932 citations
  4. 4Role of gemcitabine in cancer therapy2005 · 375 citations
  5. 5Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles2005 · 58,122 citations